Sewer sampling, the authors say, could be expanded to track other infectious diseases such as H5N1 avian flu or mpox or to detect unexpected pathogens.
Plaque growth can lead to a higher risk of heart attack, stroke, and other life-threatening cardiovascular events for as long as 1 year.
Post-exertional malaise, or exercise intolerance, was seen in 36% of those with long COVID.
Get weekly COVD-19 updates in your inbox.
Catch the latest episode!
Top COVID FAQs
By CIDRAP & other experts
Read all 7 reports
New daily cases fell 42% in the past week, deaths fell 6%, and hospitalizations fell 19%, while Americans are split on mask mandates.
Isolation beds at public hospitals have reached 90% capacity in Hong Kong, with 2,000 new cases reported.
People who received a different brand of COVID-19 vaccine booster than they did in the primary series had lower rates of infection than those who received the same brand, according to a study in Singapore published late last week in JAMA.
Patients may not know about the drugs or don't want them.
Also, protection against serious Omicron illness drops by 4 months after a third dose but is still high, new data show.
Rural counties with low COVID-19 vaccination rates had 2.4 times the risk of infection.
A new study on outcomes among infants whose mothers received the Pfizer-BioNTech mRNA vaccine in pregnancy showed that no detrimental outcomes were associated with maternal vaccination, including preterm birth, small birth weight for gestational age (SGA), congenital malformations, and infant death.
It was published yesterday in JAMA Pediatrics.
Division 1 student athletes had about half the risk of testing positive in 2020-21.
Upon approval, 10 million Pfizer vaccine doses will be ready to ship on Feb 21 and Feb 25.
A study in Qatar estimates that previous COVID-19 infection imparts 56% protection against future symptomatic infection caused by the highly transmissible Omicron variant, down from about 90% for other SARS-CoV-2 strains.
The study, published yesterday in the New England Journal of Medicine (NEJM), was led by researchers at Weill Cornell Medicine–Qatar in Doha.
